Kardiaka 15 – Acoramidis

Summary

The tender concerns the regular supply of medicines containing acoramidis for treatment of patients in approved indications according to SmPC C and current reimbursement limitations. The contract duration is 48 months from award, with an estimated total value of CZK 256,400,000. The price is the only award criterion, evaluated as the lowest price excluding VAT. Bidders must meet the qualification and compliance requirements set out in the tender documents and provide the required evidence. A bid guarantee is required at 1% of the bid price, minimum CZK 50,000 and maximum CZK 10,000,000; additional terms and conditions apply according to the tender process.